Guillain-Barré syndrome is an autoimmune neurological disease that is currently the leading cause of acute flaccid paralysis in first and second level hospitals in Mexico, usually with a history of precursor infection by Campylobacter Jejuni described as gram- negative, aerobic and motile bacilli bacteria. In Mexico, an epidemiological alert was launched on March 5, 2024, which refers to an increase in cases of Guillain-Barré with a high suspicion of a previous infection by Campylobacter Jejuni, this in the state of Tlaxcala, Mexico. As of March 29, 2024, 81 cases of acute flaccid paralysis have been reported, of these, 42 cases have been positive for Campylobacter Jejuni bacteria and 34 have been classified as Guillain-Barré syndrome, and four deaths associated with this condition have been reported.
No takes yet. Share an insight, caveat, or question.
Valenzuela et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: